-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ELspe21RTKlQ8Hchtt1FwlAk/OCqrDWDPEGIxTRfySJY4Ss5ciePE2XAzW2nAJmE HzTlWXaRdh5W5t38doQvwA== 0000919567-02-000080.txt : 20020607 0000919567-02-000080.hdr.sgml : 20020607 20020606104641 ACCESSION NUMBER: 0000919567-02-000080 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020606 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BENTLEY PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000821616 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 591513162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-40113 FILM NUMBER: 02671659 BUSINESS ADDRESS: STREET 1: 65 LAFAYETTE RD 3RD FLR CITY: NORTH HAMPTON STATE: NH ZIP: 03862 BUSINESS PHONE: 6039648006 MAIL ADDRESS: STREET 1: 65 LAFAYETTE RD 3RD FLR CITY: NORTH HAMPTON STATE: NH ZIP: 03862 FORMER COMPANY: FORMER CONFORMED NAME: BELMAC CORP /FL/ DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RENAISSANCE CAPITAL GROWTH & INCOME FUND III INC CENTRAL INDEX KEY: 0000919567 IRS NUMBER: 752533518 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 8080 N CENTRAL EXPRWY STREET 2: STE 210 LB59 CITY: DALLAS STATE: TX ZIP: 75206 BUSINESS PHONE: 2148918294 MAIL ADDRESS: STREET 1: 8080 N CENTRAL EXPWY., SUITE 210 LB 59 CITY: DALLAS STATE: TX ZIP: 75206 SC 13G/A 1 sc13ga9-05312002.txt FINAL 13G/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.9) Bentley Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 082657107 - -------------------------------------------------------------------------------- (CUSIP Number) (Page 1 of 5) CUSIP No. 082657107 13G Page 2 of 5 Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Renaissance Capital Growth & Income Fund III, Inc. 75-25333518 ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION Texax ________________________________________________________________________________ NUMBER OF 5. SOLE VOTING POWER SHARES 686,991 _________________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER OWNED BY None ________________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER REPORTING 686,991 _________________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER WITH None ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 686,991 ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 3.98% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON* IV ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 082657107 13G Page 3 of 5 Pages Item 1(a). Name of Issuer: Bentley Pharmaceuticals, Inc. ("Company") ____________________________________________________________________ Item 1(b). Address of Issuer's Principal Executive Offices: 4890 West Kennedy Blvd., #400 Tampa, FL 33609 ____________________________________________________________________ Item 2(a). Name of Person Filing: Renaissance Capital Growth & Income Fund III, Inc. ("Filer") ____________________________________________________________________ Item 2(b). Address of Principal Business Office, or if None, Residence: 8080 North Centray Expressway Suite 210, LB-59 Dallas, TX 75206-1857 ____________________________________________________________________ Item 2(c). Citizenship: Texas ____________________________________________________________________ Item 2(d). Title of Class of Securities: Common Stock ____________________________________________________________________ Item 2(e). CUSIP Number: 75966V105 ___________________________________________________________________ Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [_] Broker or dealer registered under Section 15 of the Exchange Act. (b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act. (c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [X] Investment company registered under Section 8 of the Investment Company Act. (e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). CUSIP No. 082657107 13G Page 4 of 5 Pages Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: At May 1, 2002, Renaissance Capital Growth & Income Fund III, Inc., ("Renaissance III" or "Filer") owned 774,979 shares of the Company's common stock and ten-year options to purchase 12,012 shares that vested June 9, 2001, with an exercise price of $7.25 per share. On April 30, 2002, Renaissance III sold 75,000 shares of the Company's common stock on the open market for $11.40 per share. On May 1, 2002, Renaissance III sold 25,000 shares of common stock on the open market for $11.55 per share. Thus, at May 31, 2002, the Filer owned 686,991 shares of the Company's common stock on a fully converted basis. The Investment Adviser for Renaissance III is Renaissance Capital Group, Inc., which is also Investment Manager for Renaissance US Growth and Income Trust PLC ("Renaissance US") and Investment Adviser for BFS US Special Opportunities Trust PLC ("BFS US"). Both Renaissance US and BFS US also own shares of Bentley Pharmaceuticals, Inc. ______________________________________________________________________ (b) Percent of class: 3.98% ______________________________________________________________________ (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 686,991 (ii) Shared power to vote or to direct the vote None (iii) Sole power to dispose or to direct the disposition of 686,991 (iv) Shared power to dispose or to direct the disposition of None Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following [X]. _______________________________________________________________________ Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not applicable _______________________________________________________________________ Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable _______________________________________________________________________ Item 8. Identification and Classification of Members of the Group. Not applicable CUSIP No. 082657107 13G Page 5 of 5 Pages _______________________________________________________________________ Item 9. Notice of Dissolution of Group. Not applicable _______________________________________________________________________ Item 10. Certifications. (a) The following certification shall be included if the statement is filed pursuant to Rule 13d-1(b): "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect." (b) The following certification shall be included if the statement is filed pursuant to Rule 13d-1(c): "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect." SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. June 6, 2002 ---------------------------------------- (Date) /S/ Russell Cleveland ---------------------------------------- (Signature) Russell Cleveland, President and CEO Renaissance Capital Growth & Income Fund III, Inc. ---------------------------------------- (Name/Title) -----END PRIVACY-ENHANCED MESSAGE-----